1. Home
  2. VKTX vs INTR Comparison

VKTX vs INTR Comparison

Compare VKTX & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • INTR
  • Stock Information
  • Founded
  • VKTX 2012
  • INTR 1994
  • Country
  • VKTX United States
  • INTR Brazil
  • Employees
  • VKTX N/A
  • INTR N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • INTR
  • Sector
  • VKTX Health Care
  • INTR
  • Exchange
  • VKTX Nasdaq
  • INTR Nasdaq
  • Market Cap
  • VKTX 3.5B
  • INTR 3.3B
  • IPO Year
  • VKTX 2015
  • INTR N/A
  • Fundamental
  • Price
  • VKTX $26.98
  • INTR $8.77
  • Analyst Decision
  • VKTX Strong Buy
  • INTR Hold
  • Analyst Count
  • VKTX 13
  • INTR 2
  • Target Price
  • VKTX $86.92
  • INTR $5.55
  • AVG Volume (30 Days)
  • VKTX 9.7M
  • INTR 2.7M
  • Earning Date
  • VKTX 10-22-2025
  • INTR 08-06-2025
  • Dividend Yield
  • VKTX N/A
  • INTR 0.34%
  • EPS Growth
  • VKTX N/A
  • INTR 69.31
  • EPS
  • VKTX N/A
  • INTR 0.47
  • Revenue
  • VKTX N/A
  • INTR $974,787,476.00
  • Revenue This Year
  • VKTX N/A
  • INTR $82.28
  • Revenue Next Year
  • VKTX N/A
  • INTR $21.46
  • P/E Ratio
  • VKTX N/A
  • INTR $18.77
  • Revenue Growth
  • VKTX N/A
  • INTR 38.56
  • 52 Week Low
  • VKTX $18.92
  • INTR $3.88
  • 52 Week High
  • VKTX $81.73
  • INTR $8.78
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 41.03
  • INTR 68.59
  • Support Level
  • VKTX $26.13
  • INTR $8.17
  • Resistance Level
  • VKTX $28.26
  • INTR $8.71
  • Average True Range (ATR)
  • VKTX 1.63
  • INTR 0.25
  • MACD
  • VKTX -0.39
  • INTR 0.02
  • Stochastic Oscillator
  • VKTX 19.82
  • INTR 98.86

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About INTR Inter & Co. Inc.

Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.

Share on Social Networks: